Agunmɛji e è nɔ zán dó gbɔ azɔn ɔ na é nɔ sín ninɔmɛ e mɛ é ɖè é kpo nǔ e wu é ɖè é kpo wu.
Wlɛnwín e è nɔ zán hwɛhwɛ bo nɔ kpé nukún dó mɛ wu lɛ é ɖé lɛ ɖíe:
1. Nǔ ɖěɖee nɔ zɔ́n bɔ è nɔ ɖó sìn e nɔ hu agbaza ɔ é: Wǔvɛ̌mɛji enɛ lɛ nɔ zɔ́n bɔ è nɔ ɖó sìn e nɔ hu agbaza ɔ é kpɛɖé, lobo nɔ zɔ́n bɔ è nɔ lɛ́ jɛ winnya jí.
Azɔnkwín e è nɔ ylɔ ɖɔ antihistaminiques bɔ è nɔ sà ɖò dotóoxwé ǎ lɛ é ɖi diphenhydramine (Benadryl) alǒ loratadine (Claritin) sixu wà ɖagbe ɖò azɔnkwín kpɛví lɛ mɛ.
Enyi azɔn ɔ syɛn tawun ɔ, dotóo sixu ɖè amasin e nɔ hu sìn tawun é ɖé lɛ nú mɛ.
2. Corticosteroids: Enyi antihistamines ma kpéwú ǎ ɔ, è sixu wlan corticosteroids ɖi prednisone dó ɖè nǔfúnfún kpò bo dó glɔ́n lanmɛ syɛnsyɛn.
Azɔnkwín enɛ lɛ ɔ, è nɔ nu hwɛhwɛ, bɔ ye sixu d'alɔ mɛ blewun.
3. Atakpinkpan e nɔ sú lanmɛsyɛ́nsyɛ́n sín hlɔnhlɔn sín kàn dó lanmɛ na nɔ ganji wu lɛ é: Enyi nǔɖɔbamɛ ɖevo lɛ ma nɔ wà nǔ dó nǔɖɔbamɛ sín kan e nɔ ɖó ayǐ nú hwenu gègě é wu ǎ ɔ, è sixu ɖè atakpinkpan e nɔ sú lanmɛsyɛ́nsyɛ́n sín kan dó lanmɛ na nɔ ganji wu lɛ é ɖi cyclosporine alǒ methotrexate dó mɛ, bonu é na sú lanmɛsyɛ́nsyɛ́n sín kan dó lanmɛ na nɔ ganji wu sín kan dó lanmɛ na nɔ ganji wu, bo na ɖè azɔngban ɔ kpò.
4. Omalizumab: Wǔvɛ́ ɖé wɛ amasin enɛ nyí bɔ è nɔ dó é ɖé wɛ bo nɔ dó gló globule E (IgE) e nɔ cyɔn alɔ agbaza jí bɔ è nɔ dó azɔn mɛ é, bɔ é nɔ sú ali dó globule enɛ.
È nɔ zán dó gbɔ azɔn syɛnsyɛn e nɔ ɖó sìnkɔn nú nǔ ɖevo lɛ ǎ é.
5. Ðè alɔ nú nǔ e nɔ zɔ́n bɔ è nɔ ɖó azɔn ɔ é: Nú è tuùn nǔ e nɔ zɔ́n bɔ è nɔ ɖó azɔn ɔ é, bo nyì alɔ na ɔ, é sixu d'alɔ bɔ è na nyì alɔ nú azɔn ɔ.
Nǔɖuɖu ɖé lɛ, amasin ɖé lɛ, nǔvínúví ɖuɖu, hwesivɔ kpo avivɔ kpo sixu zɔ́n bɔ nǔ nɔ nyí mɔ̌.
6. Gbadó fífá: Gbadó fífá ɖé ɖiɖó dó fí e wǔvɛ́ ɖè é sixu d'alɔ bɔ wǔvɛ́ mimɔ kpo kpo na ɖekpo.
7.Ayi e nɔ mɛ é: È sixu zán ayi e nɔ mɛ é dó gbɔ azɔn nú mɛ bo lɛ́ ɖè nǔ mɛ.
È nɔ mlá avɔ xúxú ɖé dó fí e nǔ ɔ jɛ ɖè é, bɔ è nɔ sɔ́ avɔ xúxú ɖé ɖó finɛ bo na dó hɛn sìn ɖó tɛn tɔn mɛ.
8. (Phototherapy) Wěziza e è nɔ dó mɛ lɛ é: Wěziza e nɔ zɔ́n bɔ è nɔ mɔ nǔ zɛ wu é sixu d'alɔ bɔ lanmɛsyɛ́nsyɛ́n na ɖekpo, bɔ nǔ lɛ́ɛ na ɖekpo ɖò ninɔmɛ ɖé lɛ mɛ.
É ɖò taji ɖɔ è ni yì mɔ dotóo ɖé bo na dó tuùn nǔ e wu azinzɔnnɔ ɔ ɖò azɔn mɔ wɛ é, bo lɛ́ dó gbɔ n'i.
Ye sixu d'alɔ bɔ è na tuùn nǔ e wu azɔn ɔ sín azɔn ka ɖò jijɛ wɛ é, lobo lɛ́ ɖè wlɛnwín e sɔgbe hugǎn é xlɛ́.
Deleanu D, Nedelea I, Petricau C, Leru P, Dumitrascu D, Muntean A: Clinical impact of omalizumab in refractory chronic urticaria: One centre experience. Exp Ther Med. 2019, 18 (6): 5078-5081.
Grundmann SA, Kiefer S, Luger TA, Brehler R: Delayed pressure urticaria - dapsone heading for first-line therapy? J Dtsch Dermatol Ges. 2011, 9 (11): 908-12.
Staumont-Sallé D, Piette F, Delaporte E: [Etiological diagnosis and treatment of chronic urticaria]. Rev Med Interne. 2003, 24 (1): 34-44.
Akashi R, Ishiguro N, Shimizu S, Kawashima M: Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis: effectiveness of eradication therapy for Helicobacter pylori. J Dermatol. 2011, 38 (8): 761-6.
Calogiuri G, Nettis E, Mandurino-Mirizzi A, Di Leo E, Macchia L, Foti C, Vacca A, Kounis NG: Omalizumab for the Treatment of Persistent Drug Induced Urticaria Elicited by Thienopyridines: A Case Report. Antiinflamm Antiallergy Agents Med Chem. 2020, 19 (3): 335-339.
['Nǔgbɛnúmɛ: dotóoxwé sín']
['Nǔkplɔnkplɔn kpo nǔsisɔ kpo sín azɔ̌ kɛɖɛ wɛ è nɔ wà dó tɛn ɛntɛnɛti tɔn elɔ jí, bo nɔ na wěɖexámɛ dotóoxwé tɔn alǒ azɔ̌ ɖevo lɛ mɛ ǎ.']
['È ɖó na zán nǔ e è kplɔ́n mɛ lɛ é dó ba azɔn ɖé alǒ azɔn ɖé sín wuntun alǒ dó gbɔ na ǎ, bɔ mɛ ɖěɖee jló na ba wěɖexámɛ dotóo tɔn lɛ é ɖó na yì mɔ dotóo e ɖó acɛ bo nɔ wà azɔ̌ ɖò dotóoxwé é ɖé.']
['Mi ni flín ɖɔ nǔ e è nɔ ylɔ ɖɔ "neural net" bo nɔ na xósin nú nǔkanbyɔ lɛ é ɔ, nǔ e nɔ nyí nǔjɛdo tawun é wɛ nyí nǔ ɖěɖee è nɔ ylɔ ɖɔ "numeric content" lɛ é. Ði kpɔ́ndéwú ɔ, mɛ nabi è mɔ azɔn ɖé na é.']
['Nɔ ba wěɖexámɛ dotóo towe tɔn alǒ dotóo ɖevo e ɖó nǔwukpikpé é tɔn dó azɔn ɖé wu hwebǐnu. Ma wɔn wěɖexámɛ dotóo tɔn lɛ gbeɖé ó, alǒ ma lin tamɛ kpɔ́n dó nǔ e a xà ɖò tɛn ɛntɛnɛti tɔn elɔ jí lɛ é wu ó. Enyi a lin ɖɔ azɔn baɖabaɖa ɖé ɖò xwi ɖí xá we wɛ hǔn, ylɔ 911 alǒ yì dotóoxwé e sɛkpɔ we hugǎn é tlolo. Tɛn ɛntɛnɛti tɔn elɔ alǒ nǔ e a nɔ zán lɛ é nɔ zɔ́n bɔ kancica dotóo-azinzɔnnɔ ɖé tɔn nɔ tíìn ǎ. BioMedLib, azɔ̌watɔ́ tɔn lɛ, alǒ mɛ ɖevo ɖebǔ e nɔ wlan nǔ dó tɛn ɛntɛnɛti tɔn elɔ jí lɛ é nɔ ɖè kúnnuɖenú ɖebǔ xlɛ́, bo tlɛ nɔ ɖɔ lɔ ǎ, dó nǔ e è ɖɔ ɖò fí lɛ é alǒ nǔ e è nɔ zán lɛ é wu.']
['Nǔɖògbɛ́jlatɔ́ lɛ']
['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) nɔ na acɛ mɛ e ɖó nǔɖokan yetɔn lɛ é bɔ ye na dó ba nǔɖe bo dó sixu mɔ nǔ e ye ɖó lɛ é ɖò Internet jí.']
["Enyi a ɖi nǔ ɖɔ nǔ ɖĕbǔ ɖò tɛn ɛntɛnɛti tɔn mǐtɔn jí alǒ azɔ̌wiwa mǐtɔn lɛ jí bo hɛn nǔ dó así nú mɛ ɔ, é xò nǔ dó acɛ nǔɖògbɛ́ towe lɛ wu ɔ, hwi (alǒ mɛ e nɔ kpé nukún dó wǔ towe é) sixu sɛ́ wɛn dó mǐ, bo byɔ ɖɔ mǐ ni ɖè nǔ ɖ'emɛ lɛ sín tɛn ɔ jí, alǒ ɖɔ mǐ ni sú ali dó mɛ."]
["È ɖó ná sɛ́ mɛ dó gbɔn email jí (e-mail è nɔ dó ɔ́' kpɔ́n 'Kɔntaktɔ́' ɔ́)."]
['DMCA byɔ ɖɔ ɖɔ nǔ elɔ lɛ ni nɔ akpáxwé nǔ e a ɖɔ é gbà acɛ dó nǔ é tɔn jí é: (1) xó dó azɔ̌ e ɖó acɛ dó nǔ é jí; (2) xó dó nǔ e ɖó acɛ dó nǔ é jí, kpo nǔ ɖevo e na zɔ́n bɔ mǐ na mɔ nǔ ɔ lɛ é kpo; (3) xó dó hwiɖée wu, ɖi adlɛsi towe, alokan towe kpo email towe kpo; (4) xó ɖɔ dó nǔ e wu a ɖi nǔ ɖɔ nǔ e ɖó acɛ dó nǔ e jí a ɖɔ é jí é kún nyí nǔ e ɖó acɛ dó nǔ é jí tɔn ɔ, alǒ mɛ e nɔ kpé nukún dó nǔ é tɔn wu é sín acɛ ó; ']
["(5) Ðɛ́ mɛ̀ è mi sɔ́ alɔ dó ɖ'así ná ɖò hwɛɖɔxɔsá ɔ́' è ɖó ná ɖó hwɛ̀ ɖɔ̀ xó è mi ɖɔ ɖò mɛ̀ è mi dó wèmá ɔ́ mɛ̀ ɔ́' sɔgbe bɔ̀ mi ɖó acɛ̀ bó ná dó ba ɖɔ è ní sú nǔ è è dó wèmá ɔ́ wú lɛ́ɛ sín axɔ́."]
['bɔ (6) alɔ wlanwlan mɛ e ɖó acɛ dó nǔ é tɔn alǒ mɛ e ɖó acɛ bo na wà nǔ dó wutu tɔn é tɔn. ']
['Nú a ma gɔ́ nǔ e ɖò jí lɛ é bǐ ǎ ɔ, é sixu zɔ́n bɔ è na lín có bo na dóhwɛ we.']
['Wǎ kpé mì']
['Mi kɛnklɛn bo sɛ́ nǔkanbyɔ mitɔn lɛ dó mǐ gbɔn e-mail jí.']
How to treat urticaria?
Urticaria, commonly known as hives, is a skin condition characterized by itchy, raised welts that can appear on any part of the body.
It can be caused by various factors, including allergic reactions, infections, or underlying medical conditions.
Treatment for urticaria depends on the severity of the condition and the underlying cause.
Here are some common treatment options:
1. Antihistamines: These medications help to reduce itching and swelling by blocking the effects of histamine, a chemical released by the body during an allergic reaction.
Over-the-counter antihistamines such as diphenhydramine (Benadryl) or loratadine (Claritin) can be effective in mild cases.
In more severe cases, a doctor may prescribe stronger antihistamines.
2. Corticosteroids: In cases where antihistamines are not effective, corticosteroids such as prednisone may be prescribed to reduce inflammation and suppress the immune system.
These medications are usually taken orally and can provide quick relief.
3. Immunosuppressants: In cases of chronic urticaria that do not respond to other treatments, immunosuppressant drugs such as cyclosporine or methotrexate may be prescribed to suppress the immune system and reduce inflammation.
4. Omalizumab: This medication is an injectable monoclonal antibody that targets and blocks immunoglobulin E (IgE), a protein involved in allergic reactions.
It is typically used for chronic urticaria that does not respond to other treatments.
5. Avoid triggers: Identifying and avoiding triggers that cause urticaria can help prevent outbreaks.
Common triggers include certain foods, medications, insect bites, and exposure to heat, cold, or sunlight.
6. Cold compress: Applying a cold compress to the affected area can help reduce itching and swelling.
7. Wet wraps: Wet wraps can be used to soothe itching and reduce inflammation.
A damp cloth is wrapped around the affected area, and then a dry cloth is placed over it to retain moisture.
8. Phototherapy: Exposure to ultraviolet light can help suppress the immune system and reduce inflammation in some cases of chronic urticaria.
It is important to consult a healthcare professional for proper diagnosis and treatment of urticaria.
They can help determine the underlying cause and recommend the most appropriate treatment plan.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['E ɖò']
['BioMedLib nɔ zán ordinateur lɛ (algorithme nǔ kplɔnkplɔn mɔto tɔn lɛ) bo nɔ dó kàn nǔ byɔ mɛ lɛ bo nɔ lɛ́ na ye xósin.']
['Mǐ bɛ́ kpodo azɔwanú lanmɛ kpo lanmɛ kpo tɔn livi 35 e ɖò PubMed/Medline lɛ é kpo. Mǐ lɛ́ vɔ́ mɔ tɛn ɛntɛnɛti tɔn RefinedWeb tɔn lɛ.']
